3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Myelodysplastic Syndromes
4
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Hodgkin Disease
3
Burkitt Lymphoma
3
Anemia, Refractory, with Excess of Blasts
3
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Multiple Myeloma
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Prolymphocytic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Congenital Abnormalities
2
Blast Crisis
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Interventions
Cyclophosphamide
6
fludarabine
4
Standard of Care
4
Practice Guidelines as Topic
3
Mycophenolic Acid
3
GSK2636771
3
venetoclax
2
trametinib
2
talquetamab
2
osimertinib
2
dabrafenib
2
X-Rays
2
Whole-Body Irradiation
2
Thiotepa
2
Tacrolimus
2
Specimen Handling
2
Mesna
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
Biopsy
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
thymoglobulin
1
sapanisertib
1
ruxolitinib
1
relatlimab
1
plerixafor
1
pertuzumab
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Cyclosporine
×
30 days
×
Clear all
No trials found.